Gossypol

Gossypol is a lipid of Prenol Lipids (PR) class. Gossypol is associated with abnormalities such as Paralytic Ileus, PARKINSON DISEASE, LATE-ONSET, Fibrillation, Hepatic necrosis and Lymphopenia. The involved functions are known as Atrophic, Ulcer, Necrosis, Apoptosis and antagonists. Gossypol often locates in Mucous Membrane, Epithelium, Blood, Microsomes, Liver and Autophagic vacuole. The associated genes with Gossypol are BCL2A1 gene, BCL2 gene, Transgenes, IGH@ gene cluster and Bax protein (53-86). The related lipids are Promega, proteoliposomes, Phosphatidylserines and Liposomes. The related experimental models are Transgenic Model and Xenograft Model.

Cross Reference

Introduction

To understand associated biological information of Gossypol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Gossypol?

Gossypol is suspected in Severe Combined Immunodeficiency, Aortic Valve Insufficiency, PARKINSON DISEASE, LATE-ONSET, Infertility, CLEFT LIP, CONGENITAL HEALED, Pulmonary Fibrosis and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Gossypol

MeSH term MeSH ID Detail
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Leiomyoma D007889 8 associated lipids
Nutrition Disorders D009748 6 associated lipids
Swine Diseases D013553 16 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Infertility, Female D007247 5 associated lipids
Micronuclei, Chromosome-Defective D048629 33 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Acute Lung Injury D055371 33 associated lipids
Per page 10 20 50 100 | Total 52

PubChem Associated disorders and diseases

What pathways are associated with Gossypol

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Gossypol through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Gossypol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Gossypol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Gossypol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Gossypol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Gossypol?

Xenograft Model

Xenograft Model are used in the study 'Gossypol induces apoptosis by activating p53 in prostate cancer cells and prostate tumor-initiating cells.' (Volate SR et al., 2010), Xenograft Model are used in the study 'Sorafenib sensitizes (-)-gossypol-induced growth suppression in androgen-independent prostate cancer cells via Mcl-1 inhibition and Bak activation.' (Lian J et al., 2012), Xenograft Model are used in the study 'Natural BH3 mimetic (-)-gossypol chemosensitizes human prostate cancer via Bcl-xL inhibition accompanied by increase of Puma and Noxa.' (Meng Y et al., 2008), Xenograft Model are used in the study '(-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis.' (Pang X et al., 2011) and Xenograft Model are used in the study 'Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.' (Sung B et al., 2010).

Transgenic Model

Transgenic Model are used in the study 'Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).' (Kitada S et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Gossypol

Download all related citations
Per page 10 20 50 100 | Total 1511
Authors Title Published Journal PubMed Link
Pond GR et al. Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer. 2012 Clin Genitourin Cancer pmid:23000202
Zubair H et al. Apogossypolone, derivative of gossypol, mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage. 2012 Eur J Pharm Sci pmid:22554693
Yang X et al. Identification and proteomic analysis of a novel gossypol-degrading fungal strain. 2012 J. Sci. Food Agric. pmid:22002592
Mellon JE et al. Inhibitory effects of gossypol, gossypolone, and apogossypolone on a collection of economically important filamentous fungi. 2012 J. Agric. Food Chem. pmid:22324794
Ionov M et al. Stability and antioxidant activity of gossypol derivative immobilized on N-polyvinylpyrrolidone. 2012 Int. J. Biol. Macromol. pmid:22910577
Hedvat M et al. Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules. 2012 Anticancer Agents Med Chem pmid:22931411
Varadarajan S et al. A novel cellular stress response characterised by a rapid reorganisation of membranes of the endoplasmic reticulum. 2012 Cell Death Differ. pmid:22955944
Thakur A et al. Pan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cells. 2012 PLoS ONE pmid:23185240
Jackson RS et al. Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer. 2012 Neoplasia pmid:22904682
Shen Y and Ye D Re: Gregory R. Pond, Andrew J. Armstrong, Brian A. Wood, et al. Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer. Eur Urol 2012;61:363-9. 2012 Eur. Urol. pmid:21824719
Wang Y et al. Small molecule inhibition of the steroid receptor coactivators, SRC-3 and SRC-1. 2011 Mol. Endocrinol. pmid:22053001
Ready N et al. Double-blind, placebo-controlled, randomized phase 2 study of the proapoptotic agent AT-101 plus docetaxel, in second-line non-small cell lung cancer. 2011 J Thorac Oncol pmid:21289522
Zhou DR et al. [Gossypol decreases the expression of connexin 43 in Sertoli cells]. 2011 Zhonghua Nan Ke Xue pmid:22141269
Williams JL et al. Fitness cost of resistance to Bt cotton linked with increased gossypol content in pink bollworm larvae. 2011 PLoS ONE pmid:21738799
Chang Q et al. Drug synergistic antifertility effect of combined administration of low-dose gossypol with steroid hormones in rats. 2011 Chin. Med. J. pmid:21740776
Gunassekaran GR et al. In vitro and in vivo studies on antitumor effects of gossypol on human stomach adenocarcinoma (AGS) cell line and MNNG induced experimental gastric cancer. 2011 Biochem. Biophys. Res. Commun. pmid:21782799
Yin J et al. Novel O-glycosidic gossypol isomers and their bioactivities. 2011 Carbohydr. Res. pmid:21788013
Ouyang DY et al. Valproic acid synergistically enhances the cytotoxicity of gossypol in DU145 prostate cancer cells: an iTRTAQ-based quantitative proteomic analysis. 2011 J Proteomics pmid:21726675
Li H et al. Liposomes containing (-)-gossypol-enriched cottonseed oil suppress Bcl-2 and Bcl-xL expression in breast cancer cells. 2011 Pharm. Res. pmid:21710341
Dash R et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. 2011 Proc. Natl. Acad. Sci. U.S.A. pmid:21555592
Pang X et al. (-)-Gossypol suppresses the growth of human prostate cancer xenografts via modulating VEGF signaling-mediated angiogenesis. 2011 Mol. Cancer Ther. pmid:21372225
Guo Z et al. [Gossypol acetic acid induces DNA double-strand breaks in human mucoepidermoid carcinoma cell MEC-1]. 2011 Sheng Li Xue Bao pmid:21505732
Ma X et al. Environmental inhibitors of 11β-hydroxysteroid dehydrogenase type 2. 2011 Toxicology pmid:21515335
Mao YB et al. Cotton plants expressing CYP6AE14 double-stranded RNA show enhanced resistance to bollworms. 2011 Transgenic Res. pmid:20953975
Moon DO et al. Gossypol decreases tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression via suppression of NF-κB activity. 2011 Food Chem. Toxicol. pmid:21223991
Mellon JE et al. Inhibitory effects of gossypol-related compounds on growth of Aspergillus flavus. 2011 Lett. Appl. Microbiol. pmid:21291481
Le TT et al. Evidence for a trianion intermediate in the metalation of 4-hydroxy-6,7-dimethoxy-8-methyl-2-naphthoic acid. Methodology and application to racemic 5,5'-didesisopropyl-5,5'-dialkylapogossypol derivatives. 2011 J. Org. Chem. pmid:21174400
Hu ZY et al. Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species. 2011 Chin J Cancer pmid:21192843
Baggstrom MQ et al. A phase II study of AT-101 (Gossypol) in chemotherapy-sensitive recurrent extensive-stage small cell lung cancer. 2011 J Thorac Oncol pmid:21918390
Lu Z et al. Mirabamides E-H, HIV-inhibitory depsipeptides from the sponge Stelletta clavosa. 2011 J. Nat. Prod. pmid:21280591
Zhang P et al. Suppression of jasmonic acid-dependent defense in cotton plant by the mealybug Phenacoccus solenopsis. 2011 PLoS ONE pmid:21818315
Lian J et al. A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. 2011 Cell Death Differ. pmid:20577262
Spagnuolo C et al. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation. 2011 Br. J. Cancer pmid:21750559
Amm HM et al. Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells. 2011 Mol. Cancer Res. pmid:21357440
Granchi C et al. Discovery of N-hydroxyindole-based inhibitors of human lactate dehydrogenase isoform A (LDH-A) as starvation agents against cancer cells. 2011 J. Med. Chem. pmid:21332213
Celorio-Mancera Mde L et al. Transcriptional responses underlying the hormetic and detrimental effects of the plant secondary metabolite gossypol on the generalist herbivore Helicoverpa armigera. 2011 BMC Genomics pmid:22111916
Akagunduz O et al. Radiosensitization of hormone-refractory prostate cancer cells by gossypol treatment. 2010 Oct-Dec J BUON pmid:21229643
Tiliabaev KZ et al. [Synthesis, structures, and acute toxicity of gossypol nonsymmetrical aldehyde derivatives]. 2010 May-Jun Bioorg. Khim. pmid:20644599
Chang Q et al. Effects of combined administration of low-dose gossypol with steroid hormones on the mitotic phase of spermatogenesis of rat. 2010 J Exp Zool A Ecol Genet Physiol pmid:20839281
Uzunoglu S et al. Comparison of XTT and Alamar blue assays in the assessment of the viability of various human cancer cell lines by AT-101 (-/- gossypol). 2010 Toxicol. Mech. Methods pmid:20843265
Przybylski P et al. The influence of protonation on molecular structure and physico-chemical properties of gossypol Schiff bases. 2010 Org. Biomol. Chem. pmid:20959900
Vizirianakis IS et al. Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives. 2010 J. Med. Chem. pmid:20925433
Zwitter M Combining cytotoxic and targeted therapies for lung cancer. 2010 J Thorac Oncol pmid:20871258
Lian J et al. The Bcl-2-Beclin 1 interaction in (-)-gossypol-induced autophagy versus apoptosis in prostate cancer cells. 2010 Autophagy pmid:20930561
Goldsmith KC et al. BH3 response profiles from neuroblastoma mitochondria predict activity of small molecule Bcl-2 family antagonists. 2010 Cell Death Differ. pmid:19893570
Wei J et al. BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins. 2010 J. Med. Chem. pmid:20443627
Voss V et al. The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. 2010 Mol. Cancer Res. pmid:20587533
McGregor N et al. AT-101 (R-(-)-gossypol acetic acid) enhances the effectiveness of androgen deprivation therapy in the VCaP prostate cancer model. 2010 J. Cell. Biochem. pmid:20589722
Zhang XQ et al. Apogossypolone, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces autophagy of PC-3 and LNCaP prostate cancer cells in vitro. 2010 Asian J. Androl. pmid:20657602
Li G et al. [Effect of testosterone on the expression of CMTM family of the male spermatogenesis suppression rats]. 2010 Yao Xue Xue Bao pmid:21351585